OBJECTIVES: Even though France faces few severe infections due to carbapenem-producing Enterobacterales (CPE), inter-regional epidemic stages render their dissemination a cause for...

BACKGROUND: Pneumococcal conjugate vaccines (PCVs) that are ten-valent (PCV10) and 13-valent (PCV13) became available in 2010. We evaluated their global impact on invasive pneumococcal...

Editorial. No abstract available.

Background: Within the International Health Regulations framework, the French High Council for Public Health was mandated in 2022 by health authorities to establish a list of priority...

Cardiovascular diseases (CVDs) have a multifactorial origin. Among the risk factors, so-called behavioural risk factors play a major role in the onset of these diseases: smoking,...

BACKGROUND: It has been nearly 10years since the first national stroke plan in France. AIMS: To examine the epidemiology of strokes, how they are managed and patient outcomes. METHODS:...

BACKGROUND: Peripheral arterial diseases (PADs) account for much of the morbidity and hospitalizations experienced by patients with cardiovascular disease. Epidemiological data on...

BACKGROUND: Assessing the risk of subsequent self-harm after hospitalisation for COVID-19 is critical for mental health care planning during and after the pandemic. AIMS: This study...

BACKGROUND: Demographic changes and improvements in the diagnosis and treatment of valvular heart diseases (VHDs) have led to changes in its epidemiological profile. AIMS: To describe...

BACKGROUND: Few epidemiological data are available for venous thromboembolism (VTE) at French national and subnational levels. AIMS: To quantify VTE events in France in 2022 and...